Blockbuster heart drug Entresto gets expanded indication

February 24th 2021

The FDA approved the use of Entresto in a broader group of heart failure patients that includes a large percentage of those with preserved ejection fraction.

Novo Nordisk seeks weight-loss indication for Ozempic

February 22nd 2021

Application to the FDA is based on results from a placebo-controlled trial showing a 15% decrease in body weight among those who are obese or overweight.

FDA authorizes new COVID-19 treatment; more vaccine doses on the way

February 16th 2021

FDA OKs Cosela, first-in-class therapy to protect bone marrow after chemotherapy

February 16th 2021

FDA clears BMS CAR-T cell therapy, Merck MET inhibitor

February 10th 2021

One of the new treatments available is a CAR-T cell therapy to treat relapsed or refractory large B-cell lymphoma.